AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
SHOULD THERE BE AN ACCREDITED ETHICS COMMITTEE SYSTEM FOR CENTRALIZEDREVIEW OF MULTICENTER CLINICAL RESEARCH
Authors: HENMAN MJ TATTERSALL MHN BROWN RF
Citation: Mj. Henman et al., SHOULD THERE BE AN ACCREDITED ETHICS COMMITTEE SYSTEM FOR CENTRALIZEDREVIEW OF MULTICENTER CLINICAL RESEARCH, Medical journal of Australia, 169(5), 1998, pp. 283-284
CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS
Authors: AABO K ADAMS M ADNITT P ALBERTS DS ATHANAZZIOU A BARLEY V BELL DR BIANCHI U BOLIS G BRADY MF BRODOVSKY HS BRUCKNER H BUYSE M CANETTA R CHYLAK V COHEN CJ COLOMBO N CONTE PF CROWTHER D EDMONSON JH GENNATAS C GILBEY E GORE M GUTHRIE D KAYE SB LAING AH LANDONI F LEONARD RC LEWIS C LIU PY MANGIONI C MARSONI S MEERPOHL H OMURA GA PARMAR MKB PATER J PECORELLI S PRESTI M SAUERBREI W SKARLOS DV SMALLEY RV SOLOMON HJ STEWART LA STURGEON JFG TATTERSALL MHN WHARTON JT HUININK WWT TOMIROTTI M TORRI W TROPE C TURBOW MM VERMORKEN JB WEBB MJ WILBUR DW WILLIAMS CJ WILTSHAW E YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
MEETING PATIENTS INFORMATION NEEDS BEYOND THE YEAR 2000
Authors: TATTERSALL MHN BUTOW PN ELLIS PM
Citation: Mhn. Tattersall et al., MEETING PATIENTS INFORMATION NEEDS BEYOND THE YEAR 2000, Supportive care in cancer, 5(2), 1997, pp. 85-89
THE DYNAMICS OF CHANGE - CANCER-PATIENTS PREFERENCES FOR INFORMATION,INVOLVEMENT AND SUPPORT
Authors: BUTOW PN MACLEAN M DUNN SM TATTERSALL MHN BOYER MJ
Citation: Pn. Butow et al., THE DYNAMICS OF CHANGE - CANCER-PATIENTS PREFERENCES FOR INFORMATION,INVOLVEMENT AND SUPPORT, Annals of oncology, 8(9), 1997, pp. 857-863
MEDROXYPROGESTERONE ACETATE ADDITION OR SUBSTITUTION FOR TAMOXIFEN INADVANCED TAMOXIFEN-RESISTANT BREAST-CANCER - A PHASE-III RANDOMIZED TRIAL
Authors: BYRNE MJ GEBSKI V FORBES J TATTERSALL MHN SIMES RJ COATES AS DEWAR J LUNN M FLOWER C GILL PG STEWART J
Citation: Mj. Byrne et al., MEDROXYPROGESTERONE ACETATE ADDITION OR SUBSTITUTION FOR TAMOXIFEN INADVANCED TAMOXIFEN-RESISTANT BREAST-CANCER - A PHASE-III RANDOMIZED TRIAL, Journal of clinical oncology, 15(9), 1997, pp. 3141-3148
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
SEQUENCE VARIATION IN THE UPSTREAM REGULATORY REGION OF HPV-18 ISOLATES FROM CERVICAL CANCERS
Authors: ROSE BR THOMPSON CH ZHANG JW STOETER M STEPHEN A PFISTER H TATTERSALL MHN COSSART YE
Citation: Br. Rose et al., SEQUENCE VARIATION IN THE UPSTREAM REGULATORY REGION OF HPV-18 ISOLATES FROM CERVICAL CANCERS, Gynecologic oncology, 66(2), 1997, pp. 282-289
ACTIVE SURVEILLANCE AFTER ORCHIECTOMY FOR NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS - LATE RELAPSE MAY OCCUR
Authors: BOYER MJ COX K TATTERSALL MHN FINDLAY MPN GRYGIEL J ROGERS J
Citation: Mj. Boyer et al., ACTIVE SURVEILLANCE AFTER ORCHIECTOMY FOR NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS - LATE RELAPSE MAY OCCUR, Urology, 50(4), 1997, pp. 588-592
OSTEOSARCOMA AND PULMONARY METASTASES - 15-YEAR EXPERIENCE FROM A SINGLE INSTITUTION
Authors: ELLIS PM TATTERSALL MHN MCCAUGHAN B STALLEY P
Citation: Pm. Ellis et al., OSTEOSARCOMA AND PULMONARY METASTASES - 15-YEAR EXPERIENCE FROM A SINGLE INSTITUTION, Australian and New Zealand journal of surgery, 67(9), 1997, pp. 625-629
PROGNOSTIC FACTORS FOR SURVIVAL IN CERVICAL-CANCER - WARTS AND ALL
Authors: TATTERSALL MHN ROSE BR
Citation: Mhn. Tattersall et Br. Rose, PROGNOSTIC FACTORS FOR SURVIVAL IN CERVICAL-CANCER - WARTS AND ALL, Journal of the National Cancer Institute, 88(19), 1996, pp. 1331-1332
THE EFFECT OF ADJUVANT PREDNISONE COMBINED WITH CMF ON PATTERNS OF RELAPSE AND OCCURRENCE OF 2ND MALIGNANCIES IN PATIENTS WITH BREAST-CANCER
Authors: MARINI G MURRAY S GOLDHIRSCH A GELBER RD CASTIGLIONEGERTSCH M PRICE KN TATTERSALL MHN RUDENSTAM CM COLLINS J LINDTNER J CAVALLI F CORTESFUNES H GUDGEON A FORBES JF GALLIGIONI E COATES AS SENN HJ
Citation: G. Marini et al., THE EFFECT OF ADJUVANT PREDNISONE COMBINED WITH CMF ON PATTERNS OF RELAPSE AND OCCURRENCE OF 2ND MALIGNANCIES IN PATIENTS WITH BREAST-CANCER, Annals of oncology, 7(3), 1996, pp. 245-250
ON THE RECEIVING END .5. PATIENT PERCEPTIONS OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY IN 1993
Authors: GRIFFIN AM BUTOW PN COATES AS CHILDS AM ELLIS PM DUNN SM TATTERSALL MHN
Citation: Am. Griffin et al., ON THE RECEIVING END .5. PATIENT PERCEPTIONS OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY IN 1993, Annals of oncology, 7(2), 1996, pp. 189-195
WHEN THE DIAGNOSIS IS CANCER - PATIENT COMMUNICATION EXPERIENCES AND PREFERENCES
Authors: BUTOW PN KAZEMI JN BEENEY LJ GRIFFIN AM DUNN SM TATTERSALL MHN
Citation: Pn. Butow et al., WHEN THE DIAGNOSIS IS CANCER - PATIENT COMMUNICATION EXPERIENCES AND PREFERENCES, Cancer, 77(12), 1996, pp. 2630-2637
CHARACTERISTICS OF CANCER CELL-DEATH AFTER EXPOSURE TO CYTOTOXIC DRUGS IN-VITRO
Authors: HUSCHTSCHA LI BARTIER WA ROSS CEA TATTERSALL MHN
Citation: Li. Huschtscha et al., CHARACTERISTICS OF CANCER CELL-DEATH AFTER EXPOSURE TO CYTOTOXIC DRUGS IN-VITRO, British Journal of Cancer, 73(1), 1996, pp. 54-60
CELL-DEATH BY APOPTOSIS FOLLOWING ANTICANCER DRUG-TREATMENT IN-VITRO
Authors: HUSCHTSCHA LI BARTIER WA MALMSTROM A TATTERSALL MHN
Citation: Li. Huschtscha et al., CELL-DEATH BY APOPTOSIS FOLLOWING ANTICANCER DRUG-TREATMENT IN-VITRO, International journal of oncology, 6(3), 1995, pp. 585-593
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER
Authors: CRIVELLARI D PRICE KN HAGEN M GOLDHIRSCH A GELBER RD CASTIGLIONE M COATES AS RUDENSTAM CM COLLINS J LINDTNER J CORTESFUNES H GUDGEON A SIMONCINI E BYRNE M SCHNURCH HG FEY M TATTERSALL MHN FORBES JF CAVALLI F SENN HJ
Citation: D. Crivellari et al., ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER, Annals of oncology, 6(8), 1995, pp. 769-776
COMMUNICATION WITH CANCER-PATIENTS - DOES IT MATTER
Authors: BUTOW PN DUNN SM TATTERSALL MHN
Citation: Pn. Butow et al., COMMUNICATION WITH CANCER-PATIENTS - DOES IT MATTER, Journal of palliative care, 11(4), 1995, pp. 34-38
RANDOMIZED TRIAL OF EPIRUBICIN AND CISPLATIN CHEMOTHERAPY FOLLOWED BYPELVIC RADIATION IN LOCALLY ADVANCED CERVICAL-CANCER
Authors: TATTERSALL MHN LORVIDHAYA V VOOTIPRUX V CHEIRSILPA A WONG F AZHAR T LEE HP KANG SB MANALO A YEN MS KAMPONO N AZIZ F
Citation: Mhn. Tattersall et al., RANDOMIZED TRIAL OF EPIRUBICIN AND CISPLATIN CHEMOTHERAPY FOLLOWED BYPELVIC RADIATION IN LOCALLY ADVANCED CERVICAL-CANCER, Journal of clinical oncology, 13(2), 1995, pp. 444-451
IDENTIFICATION OF E6 E7 TRANSCRIPTION PATTERNS IN HPV 16-POSITIVE CERVICAL CANCERS USING THE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION/
Authors: ROSE BR THOMPSON CH TATTERSALL MHN ELLIOTT PM DALRYMPLE C COSSART YE
Citation: Br. Rose et al., IDENTIFICATION OF E6 E7 TRANSCRIPTION PATTERNS IN HPV 16-POSITIVE CERVICAL CANCERS USING THE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION/, Gynecologic oncology, 56(2), 1995, pp. 239-244
PROVIDING INFORMATION AND OBTAINING SIGNED CONSENT TO CANCER-TREATMENT
Authors: TATTERSALL MHN LANGLANDS AO
Citation: Mhn. Tattersall et Ao. Langlands, PROVIDING INFORMATION AND OBTAINING SIGNED CONSENT TO CANCER-TREATMENT, Medical journal of Australia, 163(3), 1995, pp. 161-161
COMPUTER-BASED INTERACTION ANALYSIS OF THE CANCER CONSULTATION
Authors: BUTOW PN DUNN SM TATTERSALL MHN JONES QJ
Citation: Pn. Butow et al., COMPUTER-BASED INTERACTION ANALYSIS OF THE CANCER CONSULTATION, British Journal of Cancer, 71(5), 1995, pp. 1115-1121
5,10-DIDEAZATETRAHYDROFOLIC ACID REDUCES TOXICITY AND DEOXYADENOSINE TRIPHOSPHATE POOL EXPANSION IN CULTURED L1210 CELLS TREATED WITH INHIBITORS OF THYMIDYLATE SYNTHASE
Authors: CHONG L TATTERSALL MHN
Citation: L. Chong et Mhn. Tattersall, 5,10-DIDEAZATETRAHYDROFOLIC ACID REDUCES TOXICITY AND DEOXYADENOSINE TRIPHOSPHATE POOL EXPANSION IN CULTURED L1210 CELLS TREATED WITH INHIBITORS OF THYMIDYLATE SYNTHASE, Biochemical pharmacology, 49(6), 1995, pp. 819-827
ACTIVATION AND CYTOTOXICITY OF 2-ALPHA-AMINOACYL PRODRUGS OF METHOTREXATE
Authors: SMAL MA DONG Z CHEUNG HTA ASANO Y ESCOFFIER L COSTELLO M TATTERSALL MHN
Citation: Ma. Smal et al., ACTIVATION AND CYTOTOXICITY OF 2-ALPHA-AMINOACYL PRODRUGS OF METHOTREXATE, Biochemical pharmacology, 49(4), 1995, pp. 567-574
WRITING TO REFERRING DOCTORS AFTER A NEW PATIENT CONSULTATION - WHAT IS WANTED AND WHAT WAS CONTAINED IN LETTERS FROM ONE MEDICAL ONCOLOGIST
Authors: TATTERSALL MHN GRIFFIN A DUNN SM MONAGHAN H SCATCHARD K BUTOW PN
Citation: Mhn. Tattersall et al., WRITING TO REFERRING DOCTORS AFTER A NEW PATIENT CONSULTATION - WHAT IS WANTED AND WHAT WAS CONTAINED IN LETTERS FROM ONE MEDICAL ONCOLOGIST, Australian and New Zealand Journal of Medicine, 25(5), 1995, pp. 479-482
Risultati: 1-25 | 26-42